Acute Myeloid Leukemia (AML) is a type of cancer in which bone marrow makes abnormal blood cells. It can be difficult to treat because it progresses very rapidly. In this text interview, Dr. Rajeev Gupta talks about AML, its prevalence, risk factors, and recent guidelines. Dr. Rajeev Gupta is Associate Professor and Incharge Medical Oncology and Hematology at Sri Guru Ram Das Institute of Medical Sciences and Research, Amritsar. Dr.
Rajeev, how prevalent is Acute Myeloid Leukemia in India? Still a rare malignancy as compared to solid cancers like breast, cervix, head, and neck. About 1 per million population. Dr. Rajeev, kindly shed some light on the currently developed therapies for Acute Myeloid Leukemia treatment? Standard induction treatment with 3+7 protocol, a cure rate of about 40% in std risk. Poor outcome in the elderly (more than 60), poor risk cytogenetics like pH positive…
